References
- FisherRSCommentary: consciousness of epilepsyEpilepsia2014558115324981785
- KameiCInvolvement of central histamine in amygdaloid kindled seizures in ratsBehav Brain Res2001124224325011640977
- KameiCIshizawaKKakinokiHFukunagaMHistaminergic mechanisms in amygdaloid-kindled seizures in ratsEpilepsy Res19983031871949657646
- MiyataISaegusaHSakuraiMSeizure-modifying potential of histamine H1 antagonists: a clinical observationPediatr Int201153570670821261789
- AgoJIshikawaTMatsumotoNAshequr RahmanMKameiCMechanism of imipramine-induced seizures in amygdala-kindled ratsEpilepsy Res20067211916914292
- KakinokiHIshizawaKFukunagaMFujiiYKameiCThe effects of histamine H3-receptor antagonists on amygdaloid kindled seizures in ratsBrain Res Bull19984654614659739010
- YawataITanakaKNakagawaYWatanabeYMurashimaYLNakanoKRole of histaminergic neurons in development of epileptic seizures in EL miceBrain Res Mol Brain Res20041321131715548424
- OnoderaKYamatodaniAWatanabeTEffects of alpha-fluoromethylhistidine on locomotor activity, brain histamine and catecholamine contents in ratsMethods Find Exp Clin Pharmacol1992142971051598029
- TuomistoLTackeUIs histamine an anticonvulsive inhibitory transmitter?Neuropharmacology19862589559583022184
- ZhangLSChenZHuangYWHuWWWeiEQYanaiKEffects of endogenous histamine on seizure development of pentylenetetrazole-induced kindling in ratsPharmacology2003691273212886027
- HiraiTOkumaCHaradaCDevelopment of amygdaloid kindling in histidine decarboxylase-deficient and histamine H1 receptor-deficient miceEpilepsia200445430931315030492
- SinghEPillaiKKMehndirattaMCharacterization of a lamotrigine-resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanismsBasic Clin Pharmacol Toxicol2014115537337824674593
- KivirantaTTuomistoLAiraksinenEMHistamine in cerebrospinal fluid of children with febrile convulsionsEpilepsia19953632762807614912
- TakanoTSakaueYSokodaTSeizure susceptibility due to antihistamines in febrile seizuresPediatr Neurol201042427727920304332
- TuomistoLLozevaVValjakkaALecklinAModifying effects of histamine on circadian rhythms and neuronal excitabilityBehav Brain Res2001124212913511640965
- SadekBSaadASadeqAJalalFStarkHHistamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseasesBehav Brain Res201631241543027363923
- SadekBShehabSWiecekMAnticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanolBioorg Med Chem Lett201323174886489123891186
- SadekBSchwedJSSubramanianDNon-imidazole histamine H3 receptor ligands incorporating antiepileptic moietiesEur J Med Chem20147726927924650714
- SadekBSaadASubramanianDShafiullahMLazewskaDKiec-KononowiczcKAnticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult ratsNeuropharmacology2016106465526525191
- SadekBStarkHCherry-picked ligands at histamine receptor subtypesNeuropharmacology2016106567326581501
- FisherRSAcevedoCArzimanoglouAILAE official report: a practical clinical definition of epilepsyEpilepsia201455447548224730690
- SchwartzJCThe histamine H3 receptor: from discovery to clinical trials with pitolisantBr J Pharmacol2011163471372121615387
- KuhneSWijtmansMLimHDLeursRde EschIJSeveral down, a few to go: histamine H3 receptor ligands making the final push towards the market?Expert Opin Investig Drugs2011201216291648
- Kasteleijn-Nolst TreniteDParainDGentonPMasnouPSchwartzJCHirschEEfficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: dose-dependent effects in the human photosensitivity modelEpilepsy Behav2013281667023665640
- SadekBKuderKSubramanianDAnticonvulsive effect of nonimidazole histamine H3 receptor antagonistsBehav Pharmacol201425324525224776492
- KottkeTSanderKWeizelLSchneiderEHSeifertRStarkHReceptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligandsEur J Pharmacol2011654320020821237145
- SanderKKottkeTWeizelLStarkHKojic acid derivatives as histamine H(3) receptor ligandsChem Pharm Bull (Tokyo)201058101353136120930404
- SadekBSchreebASchwedJSWeizelLStarkHDrug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligandsDrug Des Devel Ther2014814991513
- ChengYPrusoffWHRelationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reactionBiochem Pharmacol19732223309931084202581
- LazewskaDLigneauXSchwartzJCSchunackWStarkHKiec-KononowiczKEther derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonistsBioorg Med Chem200614103522352916466921
- MeierGApeltJReichertUInfluence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonistsEur J Pharm Sci200113324925911384847
- SadekBKhanianSSAshoorAEffects of antihistamines on the function of human alpha7-nicotinic acetylcholine receptorsEur J Pharmacol201474630831625445036
- LoscherWCritical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugsSeizure201120535936821292505
- Branco CdosSScolaGRodriguesADAnticonvulsant, neuroprotective and behavioral effects of organic and conventional yerba mate (Ilex paraguariensis St. Hil.) on pentylenetetrazol-induced seizures in Wistar ratsBrain Res Bull201292606823270878
- SowemimoAAAdioOFageyinboSAnticonvulsant activity of the methanolic extract of Justicia extensa T. AndersJ Ethnopharmacol2011138369769922004892
- SanchetiJShaikhMFChaudhariRCharacterization of anticonvulsant and antiepileptogenic potential of thymol in various experimental modelsNaunyn Schmiedebergs Arch Pharmacol20133871596624065087
- CoppolaGArcieriSD’AnielloALevetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in ratsSeizure201019529629920399683
- CaliJJMaDSobolMLuminogenic cytochrome P450 assaysExpert Opin Drug Metab Toxicol20062462964516859410
- LazewskaDWiecekMNerJAryl-1,3,5-triazine derivatives as histamine H4 receptor ligandsEur J Med Chem20148353454624996140
- GrosickiMLataczGSzopaACukierAKiec-KononowiczKThe study of cellular cytotoxicity of argireline – an anti-aging peptideActa Biochim Pol2014611293224644551
- KaminskaKZiembaJNerJ(2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligandsEur J Med Chem201510323825126360048
- ArrangJMGarbargMSchwartzJCAuto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature19833028328376188956
- BhowmikMKhanamRVohoraDHistamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectivesBr J Pharmacol201216771398141422758607
- LoscherWFassbenderCPNoltingBThe role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure modelsEpilepsy Res19918279942065646
- LoscherWHonackDFassbenderCPNoltingBThe role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure modelsEpilepsy Res1991831711891907909
- CordaMGOrlandiMLeccaDCarboniGFrauVGiorgiOPentylenetetrazol-induced kindling in rats: effect of GABA function inhibitorsPharmacol Biochem Behav19914023293331805236
- BrownREStevensDRHaasHLThe physiology of brain histamineProg Neurobiol200163663767211164999
- HaasHLSergeevaOASelbachOHistamine in the nervous systemPhysiol Rev20088831183124118626069
- DaiHFuQShenYThe histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neuronsEur J Pharmacol20075631–311712317350613
- SwinyardEASofiaRDKupferbergHJComparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and ratsEpilepsia198627127343004930
- WhiteHSComparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugsEpilepsia199940suppl 5S2S10
- ShermaJPlanar chromatographyAnal Chem200274122653266212090655
- FriesnerRABanksJLMurphyRBGlide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracyJ Med Chem20044771739174915027865
- FriesnerRAMurphyRBRepaskyMPExtra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexesJ Med Chem200649216177619617034125
- HalgrenTAMurphyRBFriesnerRAGlide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screeningJ Med Chem20044771750175915027866
- CrucianiGCarosatiEDe BoeckBMetaSite: understanding metabolism in human cytochromes from the perspective of the chemistJ Med Chem200548226970697916250655
- KuderKLazewskaDLataczGChlorophenoxy aminoalkyl derivatives as histamine H(3)R ligands and antiseizure agentsBioorg Med Chem2016242537226690914
- NassarAFDrug Metabolism Handbook: Concepts and ApplicationsHoboken, NJJohn Wiley & Sons2009
- GarbargMArrangJMRouleauAS-[2-(4-imidazolyl)ethyl] isothiourea, a highly specific and potent histamine H3 receptor agonistJ Pharmacol Exp Ther199226313043101383495
- GarbargMBarbinGBischoffSPollardHSchwartzJCDual localization of histamine in an ascending neuronal pathway and in non-neuronal cells evidenced by lesions in the lateral hypothalamic areaBrain Res197610623333481084206
- GarbargMPollardHTrung TuongMDSchwartzJCGrosCSensitive radioimmunoassays for histamine and telemethylhistamine in the brainJ Neurochem1989536172417302809587
- LigneauXLinJVanni-MercierGNeurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonistJ Pharmacol Exp Ther199828726586669808693
- LigneauXGarbargMVizueteML[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptorsJ Pharmacol Exp Ther199427114524597965746
- LigneauXMorissetSTardivel-LacombeJDistinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domainBr J Pharmacol200013171247125011090094
- AmonMLigneauXCamelinJCBerrebi-BertrandISchwartzJCStarkHHighly potent fluorescence-tagged nonimidazole histamine H3 receptor ligandsChemMedChem20072570871617361979
- IsenseeKAmonMGarlapatiAFluorinated non-imidazole histamine H3 receptor antagonistsBioorg Med Chem Lett20091982172217519286376
- TomaschMSchwedJSPaulkeAStarkHBodilisant-a novel fluorescent, highly affine histamine h3 receptor ligandACS Med Chem Lett20134226927324900647
- SchibliRSchubigerPACurrent use and future potential of organometallic radiopharmaceuticalsEur J Nucl Med Mol Imaging200229111529154212397472
- SchlotterKBoecklerFHubnerHGmeinerPFancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with sub-nanomolar binding affinity and novel selectivity profilesJ Med Chem200548113696369915916420
- van StaverenDRMetzler-NolteNBioorganometallic chemistry of ferroceneChem Rev2004104125931598515584693
- SanderKKottkeTStarkHHistamine H3 receptor antagonists go to clinicsBiol Pharm Bull200831122163218119043195
- BahiASadekBNurulainSMWięcekcMKieć-KononowiczKThe histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in micePhysiol Behav201515118919726169446